Ian Arroyo - 16 Jul 2026 Form 4 Insider Report for Freightos Ltd (CRGO)

Reporting relationship
Chief Strategy Officer
Issuer ticker
CRGO
Reported as of
16 Jul 2026
Net transaction value
-$2,235
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
20 Jul 2026, 17:00:31 UTC
Prior SEC filing
07 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Max Sitnick, Attorney-in-fact

Key filing fact

Ian Arroyo filed Form 4 for Freightos Ltd (CRGO) on 20 Jul 2026.

Key facts

  • This page summarizes Ian Arroyo's Form 4 filing for Freightos Ltd (CRGO).
  • 2 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 20 Jul 2026, 17:00.

Change

  • Previous filing in this sequence was filed on 07 Jul 2026.
  • Current net transaction value: -$2,235.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001976393 Primary reporting owner

Arroyo Ian

Relationship
Chief Strategy Officer
Address
C/O FREIGHTOS LIMITED, PLANTA 10,, AVDA. DIAGONAL, 211, BARCELONA, SPAIN
Signature
/s/ Max Sitnick, Attorney-in-fact
Signature date
20 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRGO transaction

Ordinary Shares

Sale

Transaction value
$965
Shares
-760
Change %
-14%
Price
$1.27
Shares after
4,730
Date
16 Jul 2026
Ownership
Direct
Footnotes
F1, F2
CRGO transaction

Ordinary Shares

Sale

Transaction value
$1,270
Shares
-1,000
Change %
-5.1%
Price
$1.27
Shares after
18,513
Date
16 Jul 2026
Ownership
Direct
Footnotes
F1, F3
CRGO holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
23,924
Date
16 Jul 2026
Ownership
Direct
Footnotes
F4
CRGO holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
37,500
Date
16 Jul 2026
Ownership
Direct
Footnotes
F4, F5
CRGO holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
37,500
Date
16 Jul 2026
Ownership
Direct
Footnotes
F4, F6
CRGO holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
32,099
Date
16 Jul 2026
Ownership
Direct
Footnotes
F4, F7
CRGO holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
38,000
Date
16 Jul 2026
Ownership
Direct
Footnotes
F4, F8
CRGO holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
38,000
Date
16 Jul 2026
Ownership
Direct
Footnotes
F4, F9
CRGO holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
54,600
Date
16 Jul 2026
Ownership
Direct
Footnotes
F4, F10

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRGO holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
49,473
Date
16 Jul 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
49,473
Exercise price
$1.07
Footnotes
F4
CRGO holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
12,314
Date
16 Jul 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
12,314
Exercise price
$4.17
Footnotes
F4
CRGO holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
228,674
Date
16 Jul 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
228,674
Exercise price
$4.17
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 10 footnotes

Footnote F1

The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.

Footnote F2

The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 7,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting on October 15, 2025. Such RSUs have vested in full as of July 15, 2026 (reduced by any RSUs for which underlying shares have been sold to cover tax liability). In addition to the 760 shares sold as reported in this row and the 756 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 754 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 4,730 ordinary shares are currently held by the Reporting Person from the 7,000 RSUs originally granted.

Footnote F3

The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 21,500 RSUs originally granted by the Issuer to the Reporting Person that began vesting on October 15, 2025. Such RSUs vest equally on a quarterly basis over seven calendar quarters (approximately 14.286% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by July 15, 2027. In addition to the 1,000 shares sold as reported in this row and the 995 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 992 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 18,513 RSUs and/or underlying ordinary shares are currently held by the Reporting Person from the 21,500 RSUs originally granted.

Footnote F4

There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.

Footnote F5

The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2027.

Footnote F6

The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that are now fully vested and have settled for underlying ordinary shares (as of July 15, 2026).

Footnote F7

The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 36,000 RSUs originally granted to the Reporting Person by the Issuer that began vesting on July 1, 2025 and that vest (and settle for underlying ordinary shares) in accordance with the following schedule: 33.33% of the RSUs vested upon the one-year anniversary of the vesting commencement date, and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be vested by the three-year anniversary of the vesting commencement date (July 1, 2028).

Footnote F8

The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2026.

Footnote F9

The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2027.

Footnote F10

The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person that were granted to, and began vesting for, the Reporting Person on April 1, 2026 and that vest and settle for underlying ordinary shares based on the following schedule: 33% of the subject RSUs will vest upon the one-year anniversary of the grant date (April 1, 2027), and the remainder of the RSUs will vest in eight equal installments at the conclusion of each of the following eight quarters (8.25% per quarter), such that the RSUs will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2029).

SEC remarks

Exhibit List: Exhibit 24.1 - Power of Attorney.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .